Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2026-02-12 @ 2:19 PM
Study NCT ID:
NCT02081495
Status:
COMPLETED
Last Update Posted:
2016-11-11
First Post:
2014-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-05
First Submit QC Date:
None
Study First Post Date:
2014-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-10
Last Update Post Date:
2016-11-11
Last Update Post Date Type:
ESTIMATED